河南省慢性髓性白血病患者伊马替尼治疗依从性观察及其对12个月时细胞遗传学反应的影响

OBJECTIVE: To observe the compliance to Imatinib (IM) 400 mg/d in 513 patients with chronic myeloid leukemia chronic phase (CML-CP) referred to Henan Province Tumor Hospital from March 2013 through March 2015 and its influence on cytogenetic response at 12 months. METHODS: Of 513 patients with CML-C...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2016
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364999/
https://www.ncbi.nlm.nih.gov/pubmed/27535858
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2016.07.008

Ejemplares similares

Ejemplares similares